Management of Patients with Nonmalignant Hematologic Disorders

Front

________ is a condition in which the hemoglobin concentration is lower than normal, reflecting the presence of fewer than the normal number of erythrocytes within the circulatory system.

Back

Anemia

Front

A healthy person can often tolerate as much as a ________% gradual reduction in hemoglobin without pronounced symptoms or significant incapacity.

Back

50

Front

Complications of severe anemia include ________, ________, and ________.

Back

heart failure, paresthesias, delirium

Front

The overall prevalence of anemia increases with age, from ____to____% in people aged 65 to 69, to ____to____% in people over age 85.

Back

4 to 6% in people aged 65 to 69, to 13 to 14% in people over age 85.

Front

A ________ assessment should be performed for patients with known megaloblastic anemia.

Back

neurologic

Front

________ and ________ should not be taken with iron preparations, because they greatly diminish the absorption of iron.

Back

Antacids, dairy products

Front

________ is a rare disease caused by a decrease in or damage to marrow stem cells, damage to the microenvironment within the marrow, or replacement of the marrow with fat.

Back

Aplastic anemia

Front

Chronic use of ________ to reduce gastric acid production can inhibit B12 absorption, as can the use of ________ in managing diabetes.

Back

proton pump inhibitors; metformin

Front

Assessment of patients who have or are at risk for megaloblastic anemia includes inspection of the ________, ________, and ________.

Back

Skin, mucous membranes, tongue

Front

_____ is a severe hemolytic anemia that results from inheritance of the sickle hemoglobin gene, which causes the hemoglobin molecule to be defective.

Back

Sickle cell disease